A detailed history of Morgan Stanley transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 782,932 shares of TERN stock, worth $4.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
782,932
Previous 333,618 134.68%
Holding current value
$4.54 Million
Previous $2.27 Million 187.49%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $2.92 Million - $4.85 Million
449,314 Added 134.68%
782,932 $6.53 Million
Q2 2024

Oct 17, 2024

SELL
$4.54 - $8.2 $1.15 Million - $2.08 Million
-253,175 Reduced 43.15%
333,618 $2.27 Million
Q2 2024

Aug 14, 2024

SELL
$4.54 - $8.2 $1.15 Million - $2.08 Million
-253,175 Reduced 43.15%
333,618 $2.27 Million
Q1 2024

Oct 17, 2024

BUY
$4.86 - $8.19 $1.23 Million - $2.07 Million
253,175 Added 75.89%
586,793 $3.85 Million
Q1 2024

Aug 16, 2024

SELL
$4.86 - $8.19 $5.53 Million - $9.32 Million
-1,137,913 Reduced 65.98%
586,793 $3.85 Million
Q1 2024

May 15, 2024

SELL
$4.86 - $8.19 $5.53 Million - $9.32 Million
-1,137,913 Reduced 65.98%
586,793 $3.85 Million
Q4 2023

Aug 16, 2024

BUY
$3.37 - $6.86 $4.69 Million - $9.54 Million
1,391,088 Added 416.97%
1,724,706 $11.2 Million
Q4 2023

Feb 13, 2024

BUY
$3.37 - $6.86 $2.45 Million - $4.99 Million
726,946 Added 72.86%
1,724,706 $11.2 Million
Q3 2023

Nov 15, 2023

BUY
$4.7 - $8.55 $4.03 Million - $7.34 Million
858,170 Added 614.78%
997,760 $5.02 Million
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.29 $17,243 - $31,178
-2,346 Reduced 1.65%
139,590 $1.22 Million
Q1 2023

May 15, 2023

BUY
$7.91 - $12.0 $979,874 - $1.49 Million
123,878 Added 686.0%
141,936 $1.68 Million
Q4 2022

Feb 14, 2023

BUY
$4.62 - $10.18 $49,965 - $110,096
10,815 Added 149.32%
18,058 $183,000
Q3 2022

Nov 14, 2022

SELL
$1.87 - $6.42 $21,370 - $73,367
-11,428 Reduced 61.21%
7,243 $42,000
Q2 2022

Oct 27, 2022

BUY
$1.5 - $3.0 $15,270 - $30,540
10,180 Added 119.89%
18,671 $46,000
Q2 2022

Aug 15, 2022

BUY
$1.5 - $3.0 $15,270 - $30,540
10,180 Added 119.89%
18,671 $46,000
Q1 2022

Oct 27, 2022

SELL
$2.83 - $6.7 $28,809 - $68,206
-10,180 Reduced 54.52%
8,491 $25,000
Q1 2022

May 13, 2022

SELL
$2.83 - $6.7 $229,130 - $542,465
-80,965 Reduced 90.51%
8,491 $25,000
Q4 2021

Feb 14, 2022

BUY
$5.65 - $10.73 $358,277 - $680,410
63,412 Added 243.48%
89,456 $632,000
Q3 2021

Nov 15, 2021

BUY
$7.22 - $13.46 $188,037 - $350,552
26,044 New
26,044 $271,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.